Meda Biotech llc
The technology platform called HYBRID-NANOENGINEERING™.A new treatment for cancer. Discovery for synergistic effects of nanomedicine.
After 2012 things become really interesting, the value of these nano-enabled compounds will sky rocket, reaching $220 billion by 2015. More than 45% molecules, either in the market, or in research or in clinical trials or in pieline are in need of this kind of technology. We have it all. The most advanced nanotechnology platform for drug delivery. A strong patent to beat generic clift. A new cancer treatment from Meda biotech.